Trial of Celecoxib in Amyotrophic Lateral Sclerosis

Study Purpose:

To determine whether chronic treatment with celecoxib, a cyclooxygenase-2 inhibitor that has been shown to be beneficial in preclinical testing, is safe and effective in amyotrophic lateral sclerosis (ALS).

Study Status:

Not recruiting

Disease:

Amyotrophic Lateral Sclerosis (ALS) , Familial ALS , Sporadic ALS

Study Type:

Interventional

Type of Intervention:

Drug Trial

Intervention Name:

Placebo:

Phase:

N/A

Study Chair(s)/Principal Investigator(s):

Merit Cudkowicz, Massachusetts General Hospital

Clinicaltrials.gov ID:

Neals Affiliated?

Yes

Coordinating Center Contact Information